NCT02966769View on ClinicalTrials.gov

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

CompletedOBSERVATIONAL
Enrollment

294

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Non-small-Cell Lung CarcinomaSurgeryStage IIIA-N2ChemoradiationSurvival
Interventions
OTHER

Overall survival

Compare overall survival between both groups.

Trial Locations (1)

28290

Hospital Universitario Quiron Madrid, Madrid

All Listed Sponsors
lead

Grupo de Investigación Clínica en Oncología Radioterapia

OTHER

NCT02966769 - N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation | Biotech Hunter | Biotech Hunter